ClinicalTrials.Veeva

Menu

Multiparametric Characterization of Colorectal Cancers (METRAD)

R

Regional University Hospital Center (CHRU)

Status

Active, not recruiting

Conditions

Colo-rectal Cancer

Treatments

Other: Omics

Study type

Observational

Funder types

Other

Identifiers

NCT07000474
29BRC24.0393 - METRAD

Details and patient eligibility

About

The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).

Full description

Around 20% of patients with colorectal cancer present with synchronous liver metastases at the time of diagnosis. In recent years, there has been increasing interest in the high-throughput extraction of quantitative data from medical images, a technique known as radiomics. Radiomic analysis can involve both qualitative and quantitative imaging parameters, which may be used independently or integrated into multiparametric prediction models.

This is a multicenter, retrospective study designed to investigate the demographic, clinical, and radiological features, treatment regimens, and outcomes of patients diagnosed with colorectal cancer. The study will involve the collection of anonymized clinical data, including age, sex, diagnosis date, treatment details, results from histopathological and genetic analyses, as well as pre- and post-treatment medical imaging typically performed as part of the management of colorectal cancer patients, along with survival and tumor recurrence data.

PRIMARY EVALUATION CRITERIA Prediction of recurrence/treatment response based on the radiomic model.

SECONDARY EVALUATION CRITERIA The impact of CT scan image acquisition and reconstruction parameters on the prognostic model.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients who have undergone surgery for colorectal cancer.

Exclusion criteria

  • Patients under legal protection (guardianship, curatorship, etc.)
  • Refusal to participate (expressed opposition)
  • Individuals with conditions that could interfere with the study protocol or impact data integrity

Trial design

200 participants in 2 patient groups

Brest
Description:
Training cohort
Treatment:
Other: Omics
External
Description:
Validation cohort
Treatment:
Other: Omics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems